BiotechDispatch - Biotech

Latest News

New research shows drug repurposing is no 'quick-fix' in race to treat COVID-19
September 23, 2021
AusBiotech

Manufacturing opportunities in cell and gene therapies highlighted in inquiry submission
September 23, 2021
Latest News

Victoria funds creation of Health Innovation Centre at Monash
September 23, 2021

A new board chair for Rhythm Biosciences September 23, 2021
Rhythm Biosciences (ASX:RHY) has announced the appointment of a new chair with the resignation of incumbent Shane Tanner.
Latest News Japanese patent for Imugene's HER-Vaxx immunotherapy September 23, 2021
Clinical stage immuno-oncology company Imugene (ASX:IMU) has announced it has received a notice of grant from the Japanese Patent Office for its application to protect its HER-Vaxx immunotherapy.
Latest News Bionomics expands clinical trial plan for BNC210 September 21, 2021
Clinical-stage biopharmaceutical company Bionomics (ASX:BNO) has announced it will proceed with evaluating its lead clinical compound, BNC210, for the treatment of acute Social Anxiety Disorder.
AusBiotech Feedback sought on Review of the National Medicines Policy September 21, 2021
AusBiotech is seeking member feedback as it responds to the Department of Health’s Review of the National Medicines Policy.
Certa Therapeutics announces new clinical trial of investigative candidate September 21, 2021
Certa Therapeutics has announced the launch of a Phase 2 trial in Australia for a potential new treatment for Diffuse Systemic Scleroderma.
Latest News Researchers identify potential cause and treatment for obesity and insulin resistance September 21, 2021
Monash University researchers have shown for the first time that mesenteric lymphatic dysfunction is a potential cause of and therapeutic target for obesity and insulin resistance.
Latest News Another new industry minister as incumbent resigns September 21, 2021
Australia has another new industry minister following the resignation of Christian Porter after just six months in the portfolio.
Latest News Australian company's COVID-19 tests approved in Europe September 16, 2021
Australian company Microbio has announced that its COVID-19 tests have been approved for sale and use in Europe.
AusBiotech COVID-19 vaccine patent waiver will not speed up global vaccination say AusBiotech and Medicines September 16, 2021
AusBiotech and Medicines Australia have released a joint statement urging the Australian Government to not support a proposed patent waiver for COVID-19 vaccines and therapies, as it will not help global vaccination.
Latest News Chimeric appoints new experts to scientific advisory board September 16, 2021
Clinical-stage cell therapy company Chimeric Therapeutics (ASX:CHM) has announced the appointment of three highly regarded experts to its Cellular Immunotherapy Scientific Advisory Board.
Latest News New publication on Radiopharm Theranostics' RAD201 September 16, 2021
Radiopharm Theranostics has announced that its RAD201 breast cancer imaging asset has been the subject of an article published in the peer-reviewed journal Molecular Pharmaceutics.
Latest News Emyria expands psychiatry advisory to advance psychedelic-assisted therapies September 16, 2021
Data-backed drug development and care delivery company Emyria (ASX:EMD) has announced the appointment of consultant psychiatrist Dr Jeremy Tannenbaum to its clinical advisory.
Latest News Neuren completes placement to accelerate development of NNZ-2591 September 14, 2021
Neuren Pharmaceuticals (ASX:NEU) has raised $20 million through a placement of new shares to institutional and sophisticated investors at $2.05 per share.
AusBiotech Joint statement supports Australian Patent Box September 14, 2021
Australia’s health innovators have united to release a statement supporting the introduction of a patent box, and welcoming the important initiative by the federal government.
Latest News Telix Pharmaceuticals secures Italian distribution agreement September 14, 2021
Telix Pharmaceuticals (ASX:TLX) has announced an exclusive commercial distribution agreement with Bologna-based RADIUS for its prostate cancer investigational imaging product Illuccix.
Latest News Rhinomed announces deal with Victorian government September 14, 2021
Wearable nasal and respiratory technology company Rhinomed (ASX:RNO) has received an initial purchase order for one million Rhinoswabs from the Victorian Department of Health to support the state's testing capability.
Latest News $472 million investment in Australia’s health and medical research September 14, 2021
Health minister Greg Hunt has announced over $470 million in new grants for health and medical research.

Most Read

New Stories